Bimbam · 2023-05-08T15:25:03.514681Z

Has anyone read news about $IBRX or knows what is going on? Almost 300% in one month.

2Año

„NATIONAL MULTICENTER TRIAL OPENS TO STUDY IMMUNITYBIO'S TRI-AD5 CANCER
VACCINES PLUS N-803 TO PREVENT CANCER IN PEOPLE WITH LYNCH SYNDROME“ - Reuters

•

2

•

Yassin@RisingAktie

2Año

Wanted to expand my position the other day when they were at just under € 2, but then they were already slowly shooting up again. Stupid timing until the money was on deposit :(

•

2

•

Bimbam@Klambam

2Año

@RisingAktie Did not dare to buy again 😂

••

Yassin@RisingAktie

2Año

@Klambam I thought the go down again briefly, but then it knew only one direction upwards and I wanted to reduce my buy-in actually and not increase. Well, I'm just now well back in the plus. Could only have been more, if I had decided 1-2 days earlier

••

Bimbam@Klambam

2Año

@RisingAktie yes let's wait and see where the journey goes 💪🏻

•

1

•

Nico@itZNico

2Año

"The increase in share prices is likely due to the positive momentum building around the company's lead pipeline candidate, N-803. The FDA is currently reviewing a regulatory submission for N-803 in combination with Bacillus Calmette-Guerin (BGC) for the treatment of patients with bladder cancer." Source: https://www.zacks.com/stock/news/2091284/immunitybio-ibrx-stock-jumps-432-will-it-continue-to-soar

•

1

•

Bimbam@Klambam

2Año

@Clermit that did not run with as hoped. rebuy? 😂

•

1

•

MarsEquities@CircusClown

2Año

@Klambam 😑das timing was of course pure comedy . Have been holding for ages and bought some more during and before the run and sold ~1/5 of the position at 5-6 again. Now again -40% all time with the rest . I personally buy rather between 1-1.5 after if it comes so far yet. Since there is no new date I suspect that it will take at least 3-6 months until the next decision, so it has for me no particular hurry to buy if it is not just again at the 52w low rumdümpelt. Of course only my personal opinion

•

2

•

MarsEquities@CircusClown

2Año

What the others have already mentioned + general strength in biotech in recent weeks + insider buying in April by Soon-Shiong. IBRX was also sold off massively before that. YTD it is still "only" 22% up.

••

MarsEquities@CircusClown

2Año

@Clermit shovel stocks is unfortunately no longer here but on his Twitter he regularly posts updates about IBRX.

•

2

•

Bimbam@Klambam

2Año

@Clermit ah okay, thanks for the info 👍🏻

••